Reverse painting of microdissected chromosome 19 markers in ovarian carcinoma identifies a complex rearrangement map

Genes Chromosomes and Cancer

Volumn 48, Issue 2, 2009, Pages 184-193

  Micci, Francesca ^a   Weimer, Jörg ^b   Haugom, Lisbeth ^a   Skotheim, Rolf I ^a,c   Grunewald, Regina ^b   Abeler, Vera M ^a   Silins, Ilvar ^a   Lothe, Ragnhild A ^a,c   Trope, Claes G ^a   Arnold, Norbert ^b   Heim, Sverre ^a,d  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF KIEL   (Germany)

^c UNIVERSITY OF OSLO   (Norway)

^d UNIVERSITY OF OSLO   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CARCINOGENESIS; CENTROMERE; CHROMOSOME 11Q; CHROMOSOME 13; CHROMOSOME 16; CHROMOSOME 19; CHROMOSOME 21Q; CHROMOSOME 22Q; CHROMOSOME ANALYSIS; CHROMOSOME ARM; CHROMOSOME G BAND; CHROMOSOME MAP; CHROMOSOME MARKER; CHROMOSOME MICRODISSECTION; CHROMOSOME PAINTING; CHROMOSOME REARRANGEMENT; CHROMOSOME TRANSLOCATION 19; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; FUSION GENE; HUMAN; HUMAN CELL; ONCOGENE; OVARY CARCINOMA; PRIORITY JOURNAL; X CHROMOSOME;

ADENOCARCINOMA, CLEAR CELL; CHROMOSOME BANDING; CHROMOSOME BREAKAGE; CHROMOSOME MAPPING; CHROMOSOME PAINTING; CHROMOSOMES, HUMAN, PAIR 19; CYSTADENOCARCINOMA; FEMALE; GENE REARRANGEMENT; HUMANS; KARYOTYPING; MICRODISSECTION; OVARIAN NEOPLASMS; OVARY; TRANSLOCATION, GENETIC;

EID: 59949089576     PISSN: 10452257     EISSN: 10982264     Source Type: Journal    
DOI: 10.1002/gcc.20628     Document Type: Article

References (25)

1. Bello MJ, Rey JA. 1990. Chromosome aberrations in metastatic ovarian cancer: Relationship with abnormalities in primary tumors. Int J Cancer 45:50-54.
2. El-Naggar AK, Lovell M, Killary AM, Clayman GL, Batsakis JG. 1996. A mucoepidermoid carcinoma of minor salivary gland with t(11;19) (q21;p13.1) as the only karyotypic abnormality. Cancer Genet Cytogenet 87:29-33.
3. Guan XY, Cargile CB, Anzick SL, Thompson FH, Meltzer PS, Bittner ML, Taetle R, McGill JR, Trent JM. 1995. Chromosome microdissection identifies cryptic sites of DNA sequence amplification in human ovarian carcinoma. Cancer Res 55:3380-3385.
4. Horsman DE, Berean K, Durham JS. 1995. Translocation (11;19) (q21;p13.1) in mucoepidermoid carcinoma of salivary gland. Cancer Genet Cytogenet 80:165-166.
5. ISCN. 2005. An International System for Human Cytogenetic Nomenclature. Shaffer LG, Tommerup N, editors. Basel: S Karger.
6. Jenkins RB, Bartelt D, Jr., Stalboerger P, Persons D, Dahl RJ, Podratz K, Keeney G, Hartmann L. 1993. Cytogenetic studies of epithelial ovarian carcinoma. Cancer Genet Cytogenet 71:76-86.
7. Mandahl N. 1992. Methods in solid tumors. In: Rooney DE, Czepulkovski BH, editors. Human Cytogenetics-A Practical Approach, Vol. 2. Malignancy and Acquired Abnormalities. Oxford: IRL Press, pp. 155-187.
8. Micci F, Heim S. 2009. Tumors of the female genital organs. In: Heim S, Mitelman F, editors. Cancer Cytogenetics, 3rd ed. New York: Wiley-Liss.
9. Mitelman F, Johansson B, Mertens F. 2008. Mitelman database of chromosome aberrations in cancer. Available at http://cgap.nci.nih.gov/Chromosomes/ Mitelman.
10. Nakayama K, Nakayama N, Jinawath N, Salani R, Kurman RJ, Shih I, Wang TL. 2007. Amplicon profiles in ovarian serous carcinomas. Int J Cancer 120:2613-2617.
11. Nordkvist A, Gustafsson H, Juberg-Ode M, Stenman G. 1994. Recurrent rearrangements of 11q14-22 in mucoepidermoid carcinoma. Cancer Genet Cytogenet 74:77-83.
12. Park JT, Li M, Nakayama K, Mao TL, Davidson B, Zhang Z, Kurman RJ, Eberhart CG, Shih I, Wang TL. 2006. Notch3 gene amplification in ovarian cancer. Cancer Res 66:6312-6318.
13. Pejovic T, Heim S, Mandahl N, Elmfors B, Floderus UM, Furgyik S, Helm G, Willen H, Mitelman F. 1989. Consistent occurrence of a 19p+ marker chromosome and loss of 11p material in ovarian seropapillary cystadenocarcinomas. Genes Chromosomes Cancer 1:167-171.
14. Pejovic T, Heim S, Orndal C, Jin YS, Mandahl N, Willen H, Mitelman F. 1990. Simple numerical chromosome aberrations in well-differentiated malignant epithelial tumors. Cancer Genet Cytogenet 49:95-101.
15. Pejovic T, Heim S, Mandahl N, Elmfors B, Furgyik S, Floderus UM, Helm G, Willen H, Mitelman F. 1991. Bilateral ovarian carcinoma: cytogenetic evidence of unicentric origin. Int J Cancer 47:358-361.
16. Pejovic T, Heim S, Mandahl N, Baldetorp B, Elmfors B, Floderus UM, Furgyik S, Helm G, Himmelmann A, Willen H. 1992. Chromosome aberrations in 35 primary ovarian carcinomas. Genes Chromosomes Cancer 4:58-68.
17. Sato T, Saito H, Morita R, Koi S, Lee JH, Nakamura Y. 1991. Allelotype of human ovarian cancer. Cancer Res 51:5118-5122.
18. Tanaka K, Boice CR, Testa JR. 1989. Chromosome aberrations in nine patients with ovarian cancer. Cancer Genet Cytogenet 43:1-14.
19. Tavassoli FA, Devilee P. 2003. Tumors of the breast and female genital organs-World Health Organization classification of tumors. IARC Press: Lyon.
20. Thompson FH, Emerson J, Alberts D, Liu Y, Guan XY, Burgess A, Fox S, Taetle R, Weinstein R, Makar R. 1994a. Clonal chromosome abnormalities in 54 cases of ovarian carcinoma. Cancer Genet Cytogenet 73:33-45.
21. Thompson FH, Liu Y, Emerson J, Weinstein R, Makar R, Trent JM, Taetle R, Alberts DS. 1994b. Simple numeric abnormalities as primary karyotype changes in ovarian carcinoma. Genes Chromosomes Cancer 10:262-266.
22. Tonon G, Modi S, Wu L, Kubo A, Coxon AB, Komiya T, O'Neil K, Stover K, El-Naggar A, Griffin JD, Kirsch IR, Kaye FJ. 2003. t(11;19) (q21;p13) translocation in mucoepidermoid carcinoma creates a novel fusion product that disrupts a notch signaling pathway. Nat Genet 33:208-213.
23. Weimer J, Kiechle M, Senger G, Wiedemann U, Ovens-Raeder A, Schuierer S, Kautza M, Siebert R, Arnold N. 1999. An easy and reliable procedure of microdissection technique for the analysis of chromosomal breakpoints and marker chromosomes. Chromosome Res 7:355-362.
24. Weimer J, Kiechle M, Arnold N. 2000. FISH-microdissection (FISH-MD) analysis of complex chromosome rearrangements. Cytogenet Cell Genet 88:114-118.
25. Whang-Peng J, Knutsen T, Douglass EC, Chu E, Ozols RF, Hogan WM, Young RC. 1984. Cytogenetic studies in ovarian cancer. Cancer Genet Cytogenet 11:91-106.